Skip to main content

Table 2 Classification of 52 analyzable ovarian cancer patients (see Table 1) into three groups regarding the applied therapy

From: Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)

Number

Group name

Description of therapy

16

Mono

Patients received a monotherapy with one chemotherapeutic drug

3

(Mono)

Patients received a monotherapy with one chemotherapeutic drug plus a treatment with Avastin

33

Combi

Patients received a combination therapy with 2 drugs